Drug Name: | Technetium (99mTc) mertiatide |
Width: | 200px |
Tradename: | Technescan Mag3 |
Dailymedid: | Tc 99m mertiatide |
Routes Of Administration: | Intravenous |
Atc Prefix: | V09 |
Atc Suffix: | CA03 |
Legal Us: | Rx-only |
Legal Us Comment: | [1] |
Kegg: | D06039 |
Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal imaging agent that is given by intravenous injection.
It was approved for medical use in the United States in June 1990.[2]
Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.
The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide.